Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Depreciation & Amortization (CF) (2020 - 2021)

Design Therapeutics' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $82000.0 for Q4 2021.

  • For Q4 2021, Depreciation & Amortization (CF) rose 1950.0% year-over-year to $82000.0; the TTM value through Dec 2021 reached $129000.0, up 3125.0%, while the annual FY2025 figure was $622000.0, 4.36% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2021 was $82000.0 at Design Therapeutics, up from $31000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $82000.0 in Q4 2021 and bottomed at $4000.0 in Q4 2020.